| Year |
Citation |
Score |
| 2023 |
Hessl D, Mandujano Rojas K, Ferrer E, Espinal G, Famula J, Schneider A, Hagerman R, Tassone F, Rivera SM. FMR1 Carriers Report Executive Function Changes Prior to Fragile X-Associated Tremor/Ataxia Syndrome: A Longitudinal Study. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 38124331 DOI: 10.1002/mds.29695 |
0.549 |
|
| 2023 |
Tassone F, Protic D, Allen EG, Archibald AD, Baud A, Brown TW, Budimirovic DB, Cohen J, Dufour B, Eiges R, Elvassore N, Gabis LV, Grudzien SJ, Hall DA, Hessl D, et al. Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on Premutation. Cells. 12. PMID 37759552 DOI: 10.3390/cells12182330 |
0.529 |
|
| 2023 |
Aishworiya R, Tak YE, Ponzini MD, Biag HMB, Salcedo-Arellano MJ, Kim K, Tassone F, Schneider A, Thurman AJ, Abbeduto L, Hessl D, Randol JL, Bolduc FV, Lippe S, Hagerman P, et al. Adaptive, behavioral, and cognitive outcomes in individuals with fragile X syndrome with varying autism severity. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. PMID 37724826 DOI: 10.1002/jdn.10299 |
0.653 |
|
| 2023 |
Hessl D, Rojas KM, Ferrer E, Espinal G, Famula J, Schneider A, Hagerman R, Tassone F, Rivera SM. A Longitudinal Study of Executive Function in Daily Life in Male Fragile X Premutation Carriers and Association with FXTAS Conversion. Medrxiv : the Preprint Server For Health Sciences. PMID 37693384 DOI: 10.1101/2023.08.31.23294855 |
0.543 |
|
| 2023 |
Zafarullah M, Li J, Salemi MR, Phinney BS, Durbin-Johnson BP, Hagerman R, Hessl D, Rivera SM, Tassone F. Blood Proteome Profiling Reveals Biomarkers and Pathway Alterations in Fragile X PM at Risk for Developing FXTAS. International Journal of Molecular Sciences. 24. PMID 37686279 DOI: 10.3390/ijms241713477 |
0.477 |
|
| 2023 |
Berry-Kravis E, Abbeduto L, Hagerman R, Coffey CS, Cudkowicz M, Erickson CA, McDuffie A, Hessl D, Ethridge LE, Tassone F, Kaufmann WE, Friedmann K, Bullard L, Hoffmann A, Veenstra-VanderWeele J, et al. Effects of AFQ056 on language learning in fragile X syndrome. The Journal of Clinical Investigation. PMID 37651202 DOI: 10.1172/JCI171723 |
0.454 |
|
| 2023 |
Aishworiya R, Chi MH, Zafarullah M, Mendoza G, Ponzini MD, Kim K, Biag HMB, Thurman AJ, Abbeduto L, Hessl D, Randol JL, Bolduc FV, Jacquemont S, Lippé S, Hagerman P, et al. Intercorrelation of Molecular Biomarkers and Clinical Phenotype Measures in Fragile X Syndrome. Cells. 12. PMID 37508583 DOI: 10.3390/cells12141920 |
0.618 |
|
| 2023 |
Coleman J, Thompson T, Riley K, Allen K, Michalak C, Shields R, Berry-Kravis E, Hessl D. The comparison of expressed emotion of parents of individuals with fragile X syndrome to other intellectual disabilities. Journal of Applied Research in Intellectual Disabilities : Jarid. PMID 36647196 DOI: 10.1111/jar.13069 |
0.75 |
|
| 2022 |
Shields R, Kaat A, Sansone S, Michalak C, Coleman J, Thompson T, McKenzie F, Dakopolos A, Riley K, Berry-Kravis E, Widaman K, Gershon RC, Hessl D. Sensitivity of the NIH Toolbox to Detect Cognitive Change in Individuals With Intellectual and Developmental Disability. Neurology. PMID 36460468 DOI: 10.1212/WNL.0000000000201528 |
0.762 |
|
| 2022 |
Tang SJ, Giri S, Pahlavan N, Han SH, Santos ER, Espinal G, Aishworiya R, Schneider A, Hessl D, Rivera SM, Hagerman RJ. Tophaceous gout of the nose in a male premutation carrier. Clinical Case Reports. 10: e6586. PMID 36447664 DOI: 10.1002/ccr3.6586 |
0.633 |
|
| 2022 |
Tosin MHS, Stebbins GT, Goetz CG, Hagerman RJ, Hessl D, Zolecki MA, Todd PK, Leehey MA, Hall DA. Fragile X-associated tremor ataxia syndrome rating scale: Revision and content validity using a mixed method approach. Frontiers in Neurology. 13: 977380. PMID 36188408 DOI: 10.3389/fneur.2022.977380 |
0.476 |
|
| 2022 |
McLennan YA, Mosconi MW, McKenzie FJ, Famula J, Krawchuk B, Kim K, Clark CJ, Hessl D, Rivera SM, Simon TJ, Tassone F, Hagerman RJ. Prosaccade and Antisaccade Behavior in Fragile X-Associated Tremor/Ataxia Syndrome Progression. Movement Disorders Clinical Practice. 9: 473-478. PMID 35586536 DOI: 10.1002/mdc3.13449 |
0.474 |
|
| 2022 |
Famula J, Ferrer E, Hagerman RJ, Tassone F, Schneider A, Rivera SM, Hessl D. Neuropsychological changes in FMR1 premutation carriers and onset of fragile X-associated tremor/ataxia syndrome. Journal of Neurodevelopmental Disorders. 14: 23. PMID 35321639 DOI: 10.1186/s11689-022-09436-y |
0.654 |
|
| 2022 |
Proteau-Lemieux M, Knoth IS, Agbogba K, Côté V, Barlahan Biag HM, Thurman AJ, Martin CO, Bélanger AM, Rosenfelt C, Tassone F, Abbeduto LJ, Jacquemont S, Hagerman R, Bolduc F, Hessl D, et al. Corrigendum: EEG Signal Complexity Is Reduced During Resting-State in Fragile X Syndrome. Frontiers in Psychiatry. 13: 867000. PMID 35280176 DOI: 10.3389/fpsyt.2022.867000 |
0.601 |
|
| 2022 |
Wang JY, Grigsby J, Placido D, Wei H, Tassone F, Kim K, Hessl D, Rivera SM, Hagerman RJ. Clinical and Molecular Correlates of Abnormal Changes in the Cerebellum and Globus Pallidus in Fragile X Premutation. Frontiers in Neurology. 13: 797649. PMID 35211082 DOI: 10.3389/fneur.2022.797649 |
0.544 |
|
| 2021 |
Proteau-Lemieux M, Knoth IS, Agbogba K, Côté V, Barlahan Biag HM, Thurman AJ, Martin CO, Bélanger AM, Rosenfelt C, Tassone F, Abbeduto LJ, Jacquemont S, Hagerman R, Bolduc F, Hessl D, et al. EEG Signal Complexity Is Reduced During Resting-State in Fragile X Syndrome. Frontiers in Psychiatry. 12: 716707. PMID 34858220 DOI: 10.3389/fpsyt.2021.716707 |
0.602 |
|
| 2021 |
Zafarullah M, Durbin-Johnson B, Fourie ES, Hessl DR, Rivera SM, Tassone F. Metabolomic Biomarkers Are Associated With Area of the Pons in Fragile X Premutation Carriers at Risk for Developing FXTAS. Frontiers in Psychiatry. 12: 691717. PMID 34483988 DOI: 10.3389/fpsyt.2021.691717 |
0.333 |
|
| 2021 |
Kaat AJ, McKenzie FJ, Shields RH, LaForte E, Coleman J, Michalak C, Hessl DR. Assessing processing speed among individuals with intellectual and developmental disabilities: A match-to-sample paradigm. Child Neuropsychology : a Journal On Normal and Abnormal Development in Childhood and Adolescence. 1-13. PMID 34126855 DOI: 10.1080/09297049.2021.1938987 |
0.76 |
|
| 2020 |
Hessl D, Libero L, Schneider A, Kerns C, Winder-Patel B, Heath B, Lee J, Coleman C, Sharma N, Solomon M, Nordahl CW, Amaral DG. Fear Potentiated Startle in Children With Autism Spectrum Disorder: Association With Anxiety Symptoms and Amygdala Volume. Autism Research : Official Journal of the International Society For Autism Research. PMID 33372389 DOI: 10.1002/aur.2460 |
0.511 |
|
| 2020 |
Schneider A, Summers S, Tassone F, Seritan A, Hessl D, Hagerman P, Hagerman R. Women with Fragile X-associated Tremor/Ataxia Syndrome. Movement Disorders Clinical Practice. 7: 910-919. PMID 33163562 DOI: 10.1002/Mdc3.13084 |
0.667 |
|
| 2020 |
Luu S, Province H, Berry-Kravis E, Hagerman R, Hessl D, Vaidya D, Lozano R, Rosselot H, Erickson C, Kaufmann WE, Budimirovic DB. Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis. Brain Sciences. 10. PMID 32932789 DOI: 10.3390/Brainsci10090629 |
0.569 |
|
| 2020 |
Zafarullah M, Tang HT, Durbin-Johnson B, Fourie E, Hessl D, Rivera SM, Tassone F. FMR1 locus isoforms: potential biomarker candidates in fragile X-associated tremor/ataxia syndrome (FXTAS). Scientific Reports. 10: 11099. PMID 32632326 DOI: 10.1038/S41598-020-67946-Y |
0.464 |
|
| 2020 |
Shields RH, Kaat AJ, McKenzie FJ, Drayton A, Sansone SM, Coleman J, Michalak C, Riley K, Berry-Kravis E, Gershon RC, Widaman KF, Hessl D. Validation of the NIH Toolbox Cognitive Battery in intellectual disability. Neurology. PMID 32094241 DOI: 10.1212/Wnl.0000000000009131 |
0.745 |
|
| 2020 |
Crawford H, Abbeduto L, Hall SS, Hardiman R, Hessl D, Roberts JE, Scerif G, Stanfield AC, Turk J, Oliver C. Fragile X syndrome: an overview of cause, characteristics, assessment and management Paediatrics and Child Health. DOI: 10.1016/J.Paed.2020.08.007 |
0.471 |
|
| 2019 |
Kim K, Hessl D, Randol JL, Espinal GM, Schneider A, Protic D, Aydin EY, Hagerman RJ, Hagerman PJ. Association between IQ and FMR1 protein (FMRP) across the spectrum of CGG repeat expansions. Plos One. 14: e0226811. PMID 31891607 DOI: 10.1371/Journal.Pone.0226811 |
0.684 |
|
| 2019 |
Wang JY, Hessl D, Tassone F, Kim K, Hagerman RJ, Rivera SM. Interaction between ventricular expansion and structural changes in the corpus callosum and putamen in males with FMR1 normal and premutation alleles. Neurobiology of Aging. PMID 31733943 DOI: 10.1016/J.Neurobiolaging.2019.09.009 |
0.532 |
|
| 2019 |
Hessl D, Schweitzer JB, Nguyen DV, McLennan YA, Johnston C, Shickman R, Chen Y. Cognitive training for children and adolescents with fragile X syndrome: a randomized controlled trial of Cogmed. Journal of Neurodevelopmental Disorders. 11: 4. PMID 30982467 DOI: 10.1186/S11689-019-9264-2 |
0.307 |
|
| 2019 |
Weber JD, Smith E, Berry-Kravis E, Cadavid D, Hessl D, Erickson C. Voice of People with Fragile X Syndrome and Their Families: Reports from a Survey on Treatment Priorities. Brain Sciences. 9. PMID 30678024 DOI: 10.3390/Brainsci9020018 |
0.354 |
|
| 2019 |
Schmitt LM, Shaffer RC, Hessl D, Erickson C. Executive Function in Fragile X Syndrome: A Systematic Review. Brain Sciences. 9. PMID 30654486 DOI: 10.3390/brainsci9010015 |
0.326 |
|
| 2019 |
Hessl D, Harvey D, Sansone S, Crestodina C, Chin J, Joshi R, Hagerman RJ, Berry-Kravis E. Effects of mavoglurant on visual attention and pupil reactivity while viewing photographs of faces in Fragile X Syndrome. Plos One. 14: e0209984. PMID 30653533 DOI: 10.1371/journal.pone.0209984 |
0.521 |
|
| 2018 |
Erickson CA, Kaufmann WE, Budimirovic DB, Lachiewicz A, Haas-Givler B, Miller RM, Weber JD, Abbeduto L, Hessl D, Hagerman RJ, Berry-Kravis E. Best Practices in Fragile X Syndrome Treatment Development. Brain Sciences. 8. PMID 30558274 DOI: 10.3390/Brainsci8120224 |
0.556 |
|
| 2018 |
Vismara LA, McCormick CEB, Shields R, Hessl D. Extending the Parent-Delivered Early Start Denver Model to Young Children with Fragile X Syndrome. Journal of Autism and Developmental Disorders. PMID 30499037 DOI: 10.1007/S10803-018-3833-1 |
0.761 |
|
| 2018 |
Al Olaby RR, Tang HT, Durbin-Johnson B, Schneider A, Hessl D, Rivera SM, Tassone F. Assessment of Molecular Measures in Non-FXTAS Male Premutation Carriers. Frontiers in Genetics. 9: 302. PMID 30186307 DOI: 10.3389/Fgene.2018.00302 |
0.511 |
|
| 2018 |
Famula JL, McKenzie F, McLennan YA, Grigsby J, Tassone F, Hessl D, Rivera SM, Martinez-Cerdeno V, Hagerman RJ. Presence of Middle Cerebellar Peduncle Sign in Premutation Carriers Without Tremor and Ataxia. Frontiers in Neurology. 9: 695. PMID 30186228 DOI: 10.3389/fneur.2018.00695 |
0.466 |
|
| 2018 |
Shelton AL, Wang JY, Fourie E, Tassone F, Chen A, Frizzi L, Hagerman RJ, Ferrer E, Hessl D, Rivera SM. Middle Cerebellar Peduncle Width-A Novel MRI Biomarker for FXTAS? Frontiers in Neuroscience. 12: 379. PMID 29988561 DOI: 10.3389/Fnins.2018.00379 |
0.497 |
|
| 2018 |
Benyakorn S, Calub CA, Riley SJ, Schneider A, Iosif AM, Solomon M, Hessl D, Schweitzer JB. Computerized Cognitive Training in Children With Autism and Intellectual Disabilities: Feasibility and Satisfaction Study. Jmir Mental Health. 5: e40. PMID 29802090 DOI: 10.2196/Mental.9564 |
0.577 |
|
| 2018 |
Shickman R, Famula J, Tassone F, Leehey M, Ferrer E, Rivera SM, Hessl D. Age- and CGG Repeat-Related Slowing of Manual Movement in Fragile X Carriers: A Prodrome of Fragile X-Associated Tremor Ataxia Syndrome? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29389022 DOI: 10.1002/Mds.27314 |
0.455 |
|
| 2017 |
Berry-Kravis EM, Lindemann L, Jønch AE, Apostol G, Bear MF, Carpenter RL, Crawley JN, Curie A, Des Portes V, Hossain F, Gasparini F, Gomez-Mancilla B, Hessl D, Loth E, Scharf SH, et al. Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome. Nature Reviews. Drug Discovery. PMID 29217836 DOI: 10.1038/nrd.2017.221 |
0.516 |
|
| 2017 |
Jiraanont P, Sweha SR, AlOlaby RR, Silva M, Tang HT, Durbin-Johnson B, Schneider A, Espinal GM, Hagerman PJ, Rivera SM, Hessl D, Hagerman RJ, Chutabhakdikul N, Tassone F. Clinical and molecular correlates in fragile X premutation females. Eneurologicalsci. 7: 49-56. PMID 28971146 DOI: 10.1016/J.Ensci.2017.04.003 |
0.643 |
|
| 2017 |
Youssef EA, Berry-Kravis E, Czech C, Hagerman RJ, Hessl D, Wong CY, Rabbia M, Deptula D, John A, Kinch R, Drewitt P, Lindemann L, Marcinowski M, Langland R, Horn C, et al. Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28816242 DOI: 10.1038/Npp.2017.177 |
0.558 |
|
| 2017 |
Ligsay A, Van Dijck A, Nguyen DV, Lozano R, Chen Y, Bickel ES, Hessl D, Schneider A, Angkustsiri K, Tassone F, Ceulemans B, Kooy RF, Hagerman RJ. A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome. Journal of Neurodevelopmental Disorders. 9: 26. PMID 28764646 DOI: 10.1186/S11689-017-9207-8 |
0.645 |
|
| 2017 |
Erickson CA, Davenport MH, Schaefer TL, Wink LK, Pedapati EV, Sweeney JA, Fitzpatrick SE, Brown WT, Budimirovic D, Hagerman RJ, Hessl D, Kaufmann WE, Berry-Kravis E. Fragile X targeted pharmacotherapy: lessons learned and future directions. Journal of Neurodevelopmental Disorders. 9: 7. PMID 28616096 DOI: 10.1186/S11689-017-9186-9 |
0.446 |
|
| 2017 |
Wang JY, Hessl D, Hagerman RJ, Simon TJ, Tassone F, Ferrer E, Rivera SM. Abnormal trajectories in cerebellum and brainstem volumes in carriers of the fragile X premutation. Neurobiology of Aging. 55: 11-19. PMID 28391068 DOI: 10.1016/J.Neurobiolaging.2017.03.018 |
0.506 |
|
| 2016 |
Gossett A, Sansone S, Schneider A, Johnston C, Hagerman R, Tassone F, Rivera SM, Seritan AL, Hessl D. Psychiatric disorders among women with the fragile X premutation without children affected by fragile X syndrome. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. PMID 27615674 DOI: 10.1002/Ajmg.B.32496 |
0.661 |
|
| 2016 |
Hessl D, Sansone SM, Berry-Kravis E, Riley K, Widaman KF, Abbeduto L, Schneider A, Coleman J, Oaklander D, Rhodes KC, Gershon RC. The NIH Toolbox Cognitive Battery for intellectual disabilities: three preliminary studies and future directions. Journal of Neurodevelopmental Disorders. 8: 35. PMID 27602170 DOI: 10.1186/S11689-016-9167-4 |
0.564 |
|
| 2016 |
Greiss Hess L, Fitzpatrick SE, Nguyen DV, Chen Y, Gaul KN, Schneider A, Lemons Chitwood K, Eldeeb MA, Polussa J, Hessl D, Rivera S, Hagerman RJ. A Randomized, Double-Blind, Placebo-Controlled Trial of Low-Dose Sertraline in Young Children With Fragile X Syndrome. Journal of Developmental and Behavioral Pediatrics : Jdbp. PMID 27560971 DOI: 10.1097/Dbp.0000000000000334 |
0.647 |
|
| 2016 |
Schneider A, Johnston C, Tassone F, Sansone S, Hagerman RJ, Ferrer E, Rivera SM, Hessl D. Broad autism spectrum and obsessive-compulsive symptoms in adults with the fragile X premutation. The Clinical Neuropsychologist. 1-15. PMID 27355445 DOI: 10.1080/13854046.2016.1189536 |
0.658 |
|
| 2016 |
Hessl D, Grigsby J. Fragile X-associated tremor/ataxia syndrome: another phenotype of the fragile X gene. The Clinical Neuropsychologist. 1-5. PMID 27355274 DOI: 10.1080/13854046.2016.1186661 |
0.37 |
|
| 2016 |
Lozano R, Saito N, Reed D, Eldeeb M, Schneider A, Hessl D, Tassone F, Beckett L, Hagerman R. Aging in Fragile X Premutation Carriers. Cerebellum (London, England). PMID 27334385 DOI: 10.1007/S12311-016-0805-X |
0.605 |
|
| 2016 |
Wang JY, Ngo MM, Hessl D, Hagerman RJ, Rivera SM. Robust Machine Learning-Based Correction on Automatic Segmentation of the Cerebellum and Brainstem. Plos One. 11: e0156123. PMID 27213683 DOI: 10.1371/journal.pone.0156123 |
0.373 |
|
| 2015 |
Brick DJ, Nethercott HE, Montesano S, Banuelos MG, Stover AE, Schutte SS, O'Dowd DK, Hagerman RJ, Ono M, Hessl DR, Tassone F, Schwartz PH. The Autism Spectrum Disorders Stem Cell Resource at Children's Hospital of Orange County: Implications for Disease Modeling and Drug Discovery. Stem Cells Translational Medicine. 4: 1369. PMID 26508786 DOI: 10.5966/sctm.2014-0073erratum |
0.414 |
|
| 2015 |
Cordeiro L, Abucayan F, Hagerman R, Tassone F, Hessl D. Anxiety disorders in fragile X premutation carriers: Preliminary characterization of probands and non-probands. Intractable & Rare Diseases Research. 4: 123-30. PMID 26361563 DOI: 10.5582/irdr.2015.01029 |
0.517 |
|
| 2014 |
Au J, Berkowitz-Sutherland L, Schneider A, Schweitzer JB, Hessl D, Hagerman R. A feasibility trial of Cogmed working memory training in fragile X syndrome. Journal of Pediatric Genetics. 3: 147-56. PMID 27625871 DOI: 10.3233/Pge-14098 |
0.649 |
|
| 2014 |
Sansone SM, Schneider A, Bickel E, Berry-Kravis E, Prescott C, Hessl D. Improving IQ measurement in intellectual disabilities using true deviation from population norms. Journal of Neurodevelopmental Disorders. 6: 16. PMID 26491488 DOI: 10.1186/1866-1955-6-16 |
0.485 |
|
| 2014 |
Brick DJ, Nethercott HE, Montesano S, Banuelos MG, Stover AE, Schutte SS, O'Dowd DK, Hagerman RJ, Ono M, Hessl DR, Tassone F, Schwartz PH. The Autism Spectrum Disorders Stem Cell Resource at Children's Hospital of Orange County: Implications for Disease Modeling and Drug Discovery. Stem Cells Translational Medicine. 3: 1275-86. PMID 25273538 DOI: 10.5966/Sctm.2014-0073 |
0.457 |
|
| 2014 |
Lozano R, Summers S, Lozano C, Mu Y, Hessl D, Nguyen D, Tassone F, Hagerman R. Association between macroorchidism and intelligence in FMR1 premutation carriers. American Journal of Medical Genetics. Part A. 164: 2206-11. PMID 24903624 DOI: 10.1002/Ajmg.A.36624 |
0.462 |
|
| 2014 |
Ballinger EC, Cordeiro L, Chavez AD, Hagerman RJ, Hessl D. Emotion potentiated startle in fragile X syndrome. Journal of Autism and Developmental Disorders. 44: 2536-46. PMID 24816942 DOI: 10.1007/s10803-014-2125-7 |
0.473 |
|
| 2014 |
Kim SY, Burris J, Bassal F, Koldewyn K, Chattarji S, Tassone F, Hessl D, Rivera SM. Fear-specific amygdala function in children and adolescents on the fragile x spectrum: a dosage response of the FMR1 gene. Cerebral Cortex (New York, N.Y. : 1991). 24: 600-13. PMID 23146966 DOI: 10.1093/cercor/bhs341 |
0.307 |
|
| 2013 |
Wadell PM, Hagerman RJ, Hessl DR. FRAGILE X SYNDROME: PSYCHIATRIC MANIFESTATIONS, ASSESSMENT AND EMERGING THERAPIES. Current Psychiatry Reviews. 9: 53-58. PMID 25632275 DOI: 10.2174/157340013805289644 |
0.555 |
|
| 2013 |
Schneider A, Leigh MJ, Adams P, Nanakul R, Chechi T, Olichney J, Hagerman R, Hessl D. Electrocortical changes associated with minocycline treatment in fragile X syndrome. Journal of Psychopharmacology (Oxford, England). 27: 956-63. PMID 23981511 DOI: 10.1177/0269881113494105 |
0.621 |
|
| 2013 |
Schneider A, Seritan A, Tassone F, Rivera SM, Hagerman R, Hessl D. Psychiatric features in high-functioning adult brothers with fragile x spectrum disorders. The Primary Care Companion For Cns Disorders. 15. PMID 23930232 DOI: 10.4088/Pcc.12L01492 |
0.672 |
|
| 2013 |
Basuta K, Lozano R, Schneider A, Yrigollen CM, Hessl D, Hagerman RJ, Tassone F. A family with two female siblings with compound heterozygous FMR1 premutation alleles. Clinical Genetics. 85: 458-63. PMID 23786467 DOI: 10.1111/Cge.12218 |
0.65 |
|
| 2013 |
Wang JY, Hessl D, Schneider A, Tassone F, Hagerman RJ, Rivera SM. Fragile X-associated tremor/ataxia syndrome: influence of the FMR1 gene on motor fiber tracts in males with normal and premutation alleles. Jama Neurology. 70: 1022-9. PMID 23753897 DOI: 10.1001/Jamaneurol.2013.2934 |
0.622 |
|
| 2013 |
Leigh MJ, Nguyen DV, Mu Y, Winarni TI, Schneider A, Chechi T, Polussa J, Doucet P, Tassone F, Rivera SM, Hessl D, Hagerman RJ. A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndrome. Journal of Developmental and Behavioral Pediatrics : Jdbp. 34: 147-55. PMID 23572165 DOI: 10.1097/Dbp.0B013E318287Cd17 |
0.633 |
|
| 2013 |
Wang JY, Hessl D, Iwahashi C, Cheung K, Schneider A, Hagerman RJ, Hagerman PJ, Rivera SM. Influence of the fragile X mental retardation (FMR1) gene on the brain and working memory in men with normal FMR1 alleles. Neuroimage. 65: 288-98. PMID 23063447 DOI: 10.1016/J.Neuroimage.2012.09.075 |
0.573 |
|
| 2012 |
Wang JM, Koldewyn K, Hashimoto R, Schneider A, Le L, Tassone F, Cheung K, Hagerman P, Hessl D, Rivera SM. Male carriers of the FMR1 premutation show altered hippocampal-prefrontal function during memory encoding. Frontiers in Human Neuroscience. 6: 297. PMID 23115550 DOI: 10.3389/Fnhum.2012.00297 |
0.524 |
|
| 2012 |
Berry-Kravis EM, Hessl D, Rathmell B, Zarevics P, Cherubini M, Walton-Bowen K, Mu Y, Nguyen DV, Gonzalez-Heydrich J, Wang PP, Carpenter RL, Bear MF, Hagerman RJ. Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial. Science Translational Medicine. 4: 152ra127. PMID 22993294 DOI: 10.1126/Scitranslmed.3004214 |
0.545 |
|
| 2012 |
Knox A, Schneider A, Abucayan F, Hervey C, Tran C, Hessl D, Berry-Kravis E. Feasibility, reliability, and clinical validity of the Test of Attentional Performance for Children (KiTAP) in Fragile X syndrome (FXS). Journal of Neurodevelopmental Disorders. 4: 2. PMID 22958782 DOI: 10.1186/1866-1955-4-2 |
0.552 |
|
| 2012 |
Hamlin AA, Sukharev D, Campos L, Mu Y, Tassone F, Hessl D, Nguyen DV, Loesch D, Hagerman RJ. Hypertension in FMR1 premutation males with and without fragile X-associated tremor/ataxia syndrome (FXTAS). American Journal of Medical Genetics. Part A. 158: 1304-9. PMID 22528549 DOI: 10.1002/Ajmg.A.35323 |
0.496 |
|
| 2012 |
Wang JY, Hessl DH, Hagerman RJ, Tassone F, Rivera SM. Age-dependent structural connectivity effects in fragile x premutation. Archives of Neurology. 69: 482-9. PMID 22491193 DOI: 10.1001/archneurol.2011.2023 |
0.519 |
|
| 2012 |
Chonchaiya W, Au J, Schneider A, Hessl D, Harris SW, Laird M, Mu Y, Tassone F, Nguyen DV, Hagerman RJ. Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder. Human Genetics. 131: 581-9. PMID 22001913 DOI: 10.1007/S00439-011-1106-6 |
0.6 |
|
| 2012 |
Schneider A, Ballinger E, Chavez A, Tassone F, Hagerman RJ, Hessl D. Prepulse inhibition in patients with fragile X-associated tremor ataxia syndrome. Neurobiology of Aging. 33: 1045-53. PMID 20961665 DOI: 10.1016/J.Neurobiolaging.2010.09.002 |
0.677 |
|
| 2011 |
Selmeczy D, Koldewyn K, Wang JM, Lee A, Harvey D, Hessl DR, Tassone F, Adams P, Hagerman RJ, Hagerman PJ, Rivera SM. Investigation of amygdala volume in men with the fragile X premutation. Brain Imaging and Behavior. 5: 285-94. PMID 21786216 DOI: 10.1007/S11682-011-9132-5 |
0.503 |
|
| 2011 |
Hessl D, Wang JM, Schneider A, Koldewyn K, Le L, Iwahashi C, Cheung K, Tassone F, Hagerman PJ, Rivera SM. Decreased fragile X mental retardation protein expression underlies amygdala dysfunction in carriers of the fragile X premutation. Biological Psychiatry. 70: 859-65. PMID 21783174 DOI: 10.1016/J.Biopsych.2011.05.033 |
0.587 |
|
| 2011 |
Cordeiro L, Ballinger E, Hagerman R, Hessl D. Clinical assessment of DSM-IV anxiety disorders in fragile X syndrome: prevalence and characterization. Journal of Neurodevelopmental Disorders. 3: 57-67. PMID 21475730 DOI: 10.1007/S11689-010-9067-Y |
0.555 |
|
| 2011 |
Farzin F, Scaggs F, Hervey C, Berry-Kravis E, Hessl D. Reliability of eye tracking and pupillometry measures in individuals with fragile X syndrome. Journal of Autism and Developmental Disorders. 41: 1515-22. PMID 21267642 DOI: 10.1007/s10803-011-1176-2 |
0.309 |
|
| 2011 |
Bourgeois JA, Seritan AL, Casillas EM, Hessl D, Schneider A, Yang Y, Kaur I, Cogswell JB, Nguyen DV, Hagerman RJ. Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers. The Journal of Clinical Psychiatry. 72: 175-82. PMID 20816038 DOI: 10.4088/Jcp.09M05407Blu |
0.625 |
|
| 2011 |
Yuhas J, Cordeiro L, Tassone F, Ballinger E, Schneider A, Long JM, Ornitz EM, Hessl D. Brief report: Sensorimotor gating in idiopathic autism and autism associated with fragile X syndrome. Journal of Autism and Developmental Disorders. 41: 248-53. PMID 20521090 DOI: 10.1007/S10803-010-1040-9 |
0.507 |
|
| 2010 |
Chonchaiya W, Tassone F, Ashwood P, Hessl D, Schneider A, Campos L, Nguyen DV, Hagerman RJ. Autoimmune disease in mothers with the FMR1 premutation is associated with seizures in their children with fragile X syndrome. Human Genetics. 128: 539-48. PMID 20809278 DOI: 10.1007/S00439-010-0882-8 |
0.639 |
|
| 2010 |
Utari A, Adams E, Berry-Kravis E, Chavez A, Scaggs F, Ngotran L, Boyd A, Hessl D, Gane LW, Tassone F, Tartaglia N, Leehey MA, Hagerman RJ. Aging in fragile X syndrome. Journal of Neurodevelopmental Disorders. 2: 70-76. PMID 20585378 DOI: 10.1007/s11689-010-9047-2 |
0.502 |
|
| 2010 |
Ashwood P, Nguyen DV, Hessl D, Hagerman RJ, Tassone F. Plasma cytokine profiles in Fragile X subjects: is there a role for cytokines in the pathogenesis? Brain, Behavior, and Immunity. 24: 898-902. PMID 20102735 DOI: 10.1016/J.Bbi.2010.01.008 |
0.509 |
|
| 2010 |
Chonchaiya W, Au J, Schneider A, Harris SW, Cordeiro L, Hessl DR, Laird M, Utari A, Hagerman RJ. Increased Prevalence of Seizures, ASD, and ADHD in Boys with the Fragile X Premutation Journal of Developmental & Behavioral Pediatrics. 31: E1-E2. DOI: 10.1097/01.Dbp.0000390251.03412.6C |
0.603 |
|
| 2009 |
Chonchaiya W, Utari A, Pereira GM, Tassone F, Hessl D, Hagerman RJ. Broad clinical involvement in a family affected by the fragile X premutation. Journal of Developmental and Behavioral Pediatrics : Jdbp. 30: 544-51. PMID 19996900 DOI: 10.1097/DBP.0b013e3181c35f25 |
0.55 |
|
| 2009 |
Hessl D, Nguyen DV, Green C, Chavez A, Tassone F, Hagerman RJ, Senturk D, Schneider A, Lightbody A, Reiss AL, Hall S. A solution to limitations of cognitive testing in children with intellectual disabilities: the case of fragile X syndrome. Journal of Neurodevelopmental Disorders. 1: 33-45. PMID 19865612 DOI: 10.1007/S11689-008-9001-8 |
0.639 |
|
| 2009 |
Bourgeois JA, Coffey SM, Rivera SM, Hessl D, Gane LW, Tassone F, Greco C, Finucane B, Nelson L, Berry-Kravis E, Grigsby J, Hagerman PJ, Hagerman RJ. A review of fragile X premutation disorders: expanding the psychiatric perspective. The Journal of Clinical Psychiatry. 70: 852-62. PMID 19422761 DOI: 10.4088/Jcp.08M04476 |
0.56 |
|
| 2009 |
Solomon M, Hessl D, Chiu S, Olsen E, Hendren RL. Towards a neurodevelopmental model of clinical case formulation. The Psychiatric Clinics of North America. 32: 199-211. PMID 19248925 DOI: 10.1016/J.Psc.2008.11.003 |
0.312 |
|
| 2009 |
Berry-Kravis E, Hessl D, Coffey S, Hervey C, Schneider A, Yuhas J, Hutchison J, Snape M, Tranfaglia M, Nguyen DV, Hagerman R. A pilot open label, single dose trial of fenobam in adults with fragile X syndrome Journal of Medical Genetics. 46: 266-271. PMID 19126569 DOI: 10.1136/Jmg.2008.063701 |
0.634 |
|
| 2009 |
Hagerman RJ, Berry-Kravis E, Kaufmann WE, Ono MY, Tartaglia N, Lachiewicz A, Kronk R, Delahunty C, Hessl D, Visootsak J, Picker J, Gane L, Tranfaglia M. Advances in the treatment of fragile X syndrome. Pediatrics. 123: 378-90. PMID 19117905 DOI: 10.1542/peds.2008-0317 |
0.57 |
|
| 2009 |
Hessl D, Berry-Kravis E, Cordeiro L, Yuhas J, Ornitz EM, Campbell A, Chruscinski E, Hervey C, Long JM, Hagerman RJ. Prepulse inhibition in fragile X syndrome: feasibility, reliability, and implications for treatment. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 150: 545-53. PMID 18785205 DOI: 10.1002/ajmg.b.30858 |
0.54 |
|
| 2009 |
Zingerevich C, Greiss-Hess L, Lemons-Chitwood K, Harris SW, Hessl D, Cook K, Hagerman RJ. Motor abilities of children diagnosed with fragile X syndrome with and without autism. Journal of Intellectual Disability Research. 53: 11-18. PMID 18771512 DOI: 10.1111/J.1365-2788.2008.01107.X |
0.437 |
|
| 2009 |
Bourgeois JA, Coffey SM, Rivera SM, Hessl D, Gane LW, Tassone F, Greco C, Finucane B, Nelson L, Berry-Kravis E, Grigsby J, Hagerman PJ, Hagerman RJ. A Review of Fragile X Premutation Disorders The Journal of Clinical Psychiatry. 70: 852-862. DOI: 10.4088/jcp.08r04476 |
0.499 |
|
| 2008 |
Koldewyn K, Hessl D, Adams J, Tassone F, Hagerman PJ, Hagerman RJ, Rivera SM. Reduced Hippocampal Activation During Recall is Associated with Elevated FMR1 mRNA and Psychiatric Symptoms in Men with the Fragile X Premutation. Brain Imaging and Behavior. 2: 105-116. PMID 19430586 DOI: 10.1007/S11682-008-9020-9 |
0.48 |
|
| 2008 |
Harris SW, Hessl D, Goodlin-Jones B, Ferranti J, Bacalman S, Barbato I, Tassone F, Hagerman PJ, Herman H, Hagerman RJ. Autism profiles of males with fragile X syndrome. American Journal of Mental Retardation : Ajmr. 113: 427-38. PMID 19127654 DOI: 10.1352/2008.113:427-438 |
0.538 |
|
| 2008 |
García-Nonell C, Ratera ER, Harris S, Hessl D, Ono MY, Tartaglia N, Marvin E, Tassone F, Hagerman RJ. Secondary medical diagnosis in fragile X syndrome with and without autism spectrum disorder. American Journal of Medical Genetics. Part A. 146: 1911-6. PMID 18627038 DOI: 10.1002/Ajmg.A.32290 |
0.549 |
|
| 2008 |
Brega AG, Goodrich G, Bennett RE, Hessl D, Engle K, Leehey MA, Bounds LS, Paulich MJ, Hagerman RJ, Hagerman PJ, Cogswell JB, Tassone F, Reynolds A, Kooken R, Kenny M, et al. The primary cognitive deficit among males with fragile X-associated tremor/ataxia syndrome (FXTAS) is a dysexecutive syndrome. Journal of Clinical and Experimental Neuropsychology. 30: 853-69. PMID 18608667 DOI: 10.1080/13803390701819044 |
0.563 |
|
| 2008 |
Grigsby J, Brega AG, Engle K, Leehey MA, Hagerman RJ, Tassone F, Hessl D, Hagerman PJ, Cogswell JB, Bennett RE, Cook K, Hall DA, Bounds LS, Paulich MJ, Reynolds A. Cognitive profile of fragile X premutation carriers with and without fragile X-associated tremor/ataxia syndrome. Neuropsychology. 22: 48-60. PMID 18211155 DOI: 10.1037/0894-4105.22.1.48 |
0.54 |
|
| 2008 |
Hessl D, Tassone F, Cordeiro L, Koldewyn K, McCormick C, Green C, Wegelin J, Yuhas J, Hagerman RJ. Brief report: aggression and stereotypic behavior in males with fragile X syndrome--moderating secondary genes in a "single gene" disorder. Journal of Autism and Developmental Disorders. 38: 184-9. PMID 17340199 DOI: 10.1007/S10803-007-0365-5 |
0.47 |
|
| 2008 |
Hagerman R, Berry-Kravis E, Hessl D, Coffey S, Schneider A, Nguyen D, Hervey C, Hutchison J, Snape M. Trial of fenobam, an mGluR5 antagonist, in adults with Fragile X Syndrome Journal of Intellectual Disability Research. 52: 814-814. DOI: 10.1111/J.1365-2788.2008.01119_9.X |
0.65 |
|
| 2007 |
Bourgeois JA, Cogswell JB, Hessl D, Zhang L, Ono MY, Tassone F, Farzin F, Brunberg JA, Grigsby J, Hagerman RJ. Cognitive, anxiety and mood disorders in the fragile X-associated tremor/ataxia syndrome. General Hospital Psychiatry. 29: 349-56. PMID 17591512 DOI: 10.1016/J.Genhosppsych.2007.03.003 |
0.543 |
|
| 2007 |
McConkie-Rosell A, Abrams L, Finucane B, Cronister A, Gane LW, Coffey SM, Sherman S, Nelson LM, Berry-Kravis E, Hessl D, Chiu S, Street N, Vatave A, Hagerman RJ. Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders. Journal of Genetic Counseling. 16: 593-606. PMID 17497108 DOI: 10.1007/s10897-007-9099-y |
0.545 |
|
| 2007 |
Solomon M, Hessl D, Chiu S, Hagerman R, Hendren R. A genetic etiology of pervasive developmental disorder guides treatment. The American Journal of Psychiatry. 164: 575-80. PMID 17403969 DOI: 10.1176/Ajp.2007.164.4.575 |
0.493 |
|
| 2007 |
Chiu S, Wegelin JA, Blank J, Jenkins M, Day J, Hessl D, Tassone F, Hagerman R. Early acceleration of head circumference in children with fragile x syndrome and autism. Journal of Developmental and Behavioral Pediatrics : Jdbp. 28: 31-5. PMID 17353729 DOI: 10.1097/01.Dbp.0000257518.60083.2D |
0.531 |
|
| 2007 |
Grigsby J, Brega AG, Leehey MA, Goodrich GK, Jacquemont S, Loesch DZ, Cogswell JB, Epstein J, Wilson R, Jardini T, Gould E, Bennett RE, Hessl D, Cohen S, Cook K, et al. Impairment of executive cognitive functioning in males with fragile X-associated tremor/ataxia syndrome. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 645-50. PMID 17266074 DOI: 10.1002/Mds.21359 |
0.543 |
|
| 2007 |
Hessl D, Rivera S, Koldewyn K, Cordeiro L, Adams J, Tassone F, Hagerman PJ, Hagerman RJ. Amygdala dysfunction in men with the fragile X premutation. Brain : a Journal of Neurology. 130: 404-16. PMID 17166860 DOI: 10.1093/Brain/Awl338 |
0.535 |
|
| 2007 |
Leehey MA, Berry-Kravis E, Min SJ, Hall DA, Rice CD, Zhang L, Grigsby J, Greco CM, Reynolds A, Lara R, Cogswell J, Jacquemont S, Hessl DR, Tassone F, Hagerman R, et al. Progression of tremor and ataxia in male carriers of the FMR1 premutation. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 203-6. PMID 17133502 DOI: 10.1002/Mds.21252 |
0.514 |
|
| 2007 |
Loesch DZ, Bui QM, Dissanayake C, Clifford S, Gould E, Bulhak-Paterson D, Tassone F, Taylor AK, Hessl D, Hagerman R, Huggins RM. Molecular and cognitive predictors of the continuum of autistic behaviours in fragile X. Neuroscience and Biobehavioral Reviews. 31: 315-26. PMID 17097142 DOI: 10.1016/J.Neubiorev.2006.09.007 |
0.588 |
|
| 2006 |
Bourgeois JA, Farzin F, Brunberg JA, Tassone F, Hagerman P, Zhang L, Hessl D, Hagerman R. Dementia with mood symptoms in a fragile X premutation carrier with the fragile X-associated tremor/ataxia syndrome: clinical intervention with donepezil and venlafaxine. The Journal of Neuropsychiatry and Clinical Neurosciences. 18: 171-7. PMID 16720793 DOI: 10.1176/Appi.Neuropsych.18.2.171 |
0.593 |
|
| 2006 |
Farzin F, Perry H, Hessl D, Loesch D, Cohen J, Bacalman S, Gane L, Tassone F, Hagerman P, Hagerman R. Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation. Journal of Developmental and Behavioral Pediatrics : Jdbp. 27: S137-44. PMID 16685180 DOI: 10.1097/00004703-200604002-00012 |
0.532 |
|
| 2005 |
Hessl D, Tassone F, Loesch DZ, Berry-Kravis E, Leehey MA, Gane LW, Barbato I, Rice C, Gould E, Hall DA, Grigsby J, Wegelin JA, Harris S, Lewin F, Weinberg D, et al. Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 139: 115-21. PMID 16184602 DOI: 10.1002/Ajmg.B.30241 |
0.494 |
|
| 2005 |
Mothersead PK, Conrad K, Hagerman RJ, Greco CM, Hessl D, Tassone F. GRAND ROUNDS: an atypical progressive dementia in a male carrier of the fragile X premutation: an example of fragile X-associated tremor/ataxia syndrome. Applied Neuropsychology. 12: 169-78. PMID 16131344 DOI: 10.1207/S15324826An1203_7 |
0.552 |
|
| 2005 |
Farzin F, Perry H, Hessl D, Loesch DZ, Cohen J, Gane LW, Kradin M, Hagerman RJ. 93 AUTISM SPECTRUM DISORDERS IN BOYS WITH THE FRAGILE X PREMUTATION Journal of Investigative Medicine. 53: S93.6-S94. DOI: 10.2310/6650.2005.00005.92 |
0.476 |
|
| 2003 |
Glaser B, Hessl D, Dyer-Friedman J, Johnston C, Wisbeck J, Taylor A, Reiss A. Biological and environmental contributions to adaptive behavior in fragile X syndrome. American Journal of Medical Genetics. Part A. 117: 21-9. PMID 12548736 DOI: 10.1002/ajmg.a.10549 |
0.331 |
|
| 2002 |
Tamm L, Menon V, Johnston CK, Hessl DR, Reiss AL. fMRI study of cognitive interference processing in females with fragile X syndrome. Journal of Cognitive Neuroscience. 14: 160-71. PMID 11970783 DOI: 10.1162/089892902317236812 |
0.303 |
|
| 2001 |
Hessl D, Dyer-Friedman J, Glaser B, Wisbeck J, Barajas RG, Taylor A, Reiss AL. The influence of environmental and genetic factors on behavior problems and autistic symptoms in boys and girls with fragile X syndrome. Pediatrics. 108: E88. PMID 11694672 |
0.309 |
|
| Show low-probability matches. |